|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01518 NC HEALTHCARE
Nominal 
0.800 0.000 (0.000%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 304,528 | -26.788% | 846,496 | 933,073 | 636,459 | 632,565 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (35,307) | 3944.330% | (5,802) | (32,432) | (290,202) | (22,592) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 911 | -28.605% | 2,265 | (80) | (27) | (703) | |
| Profit / (Loss) before Taxation | (41,088) | -- | 141,544 | 166,142 | (289,853) | (59,147) | |
| Taxation | (17,719) | -25.744% | (47,762) | (34,053) | (1,720) | (26,115) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (6,427) | -72.194% | (46,404) | (47,925) | (6,161) | (16,199) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (65,234) | -- | 47,378 | 84,164 | (297,734) | (101,461) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,904 | 29.524% | 2,691 | 5,587 | 3,317 | 13,594 |
| Depreciation & Amortisation | 25,032 | -7.573% | 51,697 | 59,982 | 70,249 | 86,621 |
| Directors' Emoluments | -- | -- | 7,033 | 6,334 | 5,852 | 5,570 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -14.000 | -- | 10.000 | 17.000 | -62.000 | -21.000 |
| DPS (cts) | 0.000 | -- | 2.039 | 3.428 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 20.389% | 20.164% | -- | -- |
| Cash flow per share ($) | -- | -- | 0.281 | 0.329 | 0.158 | 0.046 |
| NBV per share ($) | 0.977 | -- | 1.130 | 1.066 | 0.894 | 1.505 |
| Remarks: | Real time quote last updated: 11/09/2025 17:16 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -65,234 |
| %Change | -- |
| EPS / (LPS) | RMB -0.140 |
| NBV Per Share (¥) | RMB 0.977 |